Insider trades
Jason Lettmann, CEO of Alx Oncology Holdings ALXO, has filed 3 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $26.7K. The latest trade was on 03/19.
Jason Lettmann
CEO
- Company
- Alx Oncology Holdings ALXO
- First filing
- 23/06/22
- Trades
- 18 trades
- Buys / sales
- 3 / 3
- 12-month net buying
- −$26.7K
- Last trade
- 03/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 03/19 | 03/23 | 12,311 sh | $2.17 | $26,714.87 | −4.0% | |
ALXO | Open-market buy | 25/09/16–25/09/17 | 25/09/18 | 92,233 sh2 trades | $1.08avg. | $99,400.94 | +43.3% |
| Open-market sale | 25/08/15 | 25/08/19 | 2,382 sh | $0.64 | $1,524.48 | −1.1% | |
| Open-market sale | 25/02/19 | 25/02/21 | 2,159 sh | $1.15 | $2,482.85 | −1.3% | |
| Open-market buy | 24/03/14 | 24/03/18 | 4,400 sh | $11.31 | $49,764 | +2.6% |